histological confirmed advanced well differentiated carcinoid tumors of the lung or thymus
Item
histological confirmed advanced well differentiated typical and atypical carcinoid tumors of the lung or thymus
boolean
C0449575 (UMLS CUI [1,1])
C0205615 (UMLS CUI [1,2])
C0280089 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,4])
C0449575 (UMLS CUI [2,1])
C0205615 (UMLS CUI [2,2])
C0007095 (UMLS CUI [2,3])
C0040113 (UMLS CUI [2,4])
C0205179 (UMLS CUI [2,5])
patients of all treatment lines including naive patients
Item
patients of all treatment lines including naive patients can be enrolled
boolean
C0087111 (UMLS CUI [1,1])
C2200127 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0206695 (UMLS CUI [2,2])
C0040113 (UMLS CUI [2,3])
C0332155 (UMLS CUI [3,1])
C2200127 (UMLS CUI [3,2])
C0332155 (UMLS CUI [4,1])
C0206695 (UMLS CUI [4,2])
C0040113 (UMLS CUI [4,3])
at least one measurable lesion of disease on ct scan or mri
Item
at least one measurable lesion of disease on ct scan or mri
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C2200127 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C2200127 (UMLS CUI [2,3])
C1513041 (UMLS CUI [3,1])
C0040405 (UMLS CUI [3,2])
C0206695 (UMLS CUI [3,3])
C0040113 (UMLS CUI [3,4])
C1513041 (UMLS CUI [4,1])
C0024485 (UMLS CUI [4,2])
C0206695 (UMLS CUI [4,3])
C0040113 (UMLS CUI [4,4])
radiological documentation of disease progression prior to randomization
Item
radiological documentation of disease progression within 12 months prior to randomization
boolean
C0332185 (UMLS CUI [1,1])
C1290916 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,3])
adequate liver, renal and bone marrow function
Item
adequate liver, renal and bone marrow function
boolean
C0205410 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0205410 (UMLS CUI [2,1])
C0232804 (UMLS CUI [2,2])
C0205410 (UMLS CUI [3,1])
C0005953 (UMLS CUI [3,2])
C0678852 (UMLS CUI [3,3])
who performance status
Item
who performance status 0-2
boolean
C1298650 (UMLS CUI [1])
poorly differentiated neuroendocrine carcinoma
Item
poorly differentiated neuroendocrine carcinoma
boolean
C0205617 (UMLS CUI [1,1])
C0206695 (UMLS CUI [1,2])
non-neuroendocrine thymoma
Item
non-neuroendocrine thymoma
boolean
C0040100 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0206695 (UMLS CUI [1,3])
patients with severe functional disease requiring treatment with somatostatin analogs
Item
patients with severe functional disease requiring symptomatic treatment with somatostatin analogs
boolean
C0277785 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0732165 (UMLS CUI [1,4])
prior therapy with mtor inhibitors
Item
prior therapy with mtor inhibitors
boolean
C1514463 (UMLS CUI [1,1])
C2746052 (UMLS CUI [1,2])
history of liver disease
Item
history of liver disease
boolean
C0262926 (UMLS CUI [1,1])
C0023895 (UMLS CUI [1,2])
baseline qtcf
Item
baseline qtcf> 470 msec
boolean
C1442488 (UMLS CUI [1,1])
C1882513 (UMLS CUI [1,2])
uncontrolled diabetes mellitus despite adequate therapy
Item
uncontrolled diabetes mellitus despite adequate therapy
boolean
C0011849 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0205411 (UMLS CUI [1,4])